Skip to main content

Dermfoot: 16 Dermfoot 2023 : Eckart Haneke, MD, PhD - Surgery for Rare Nail Pathology.

Dermfoot 2023 : Eckart Haneke, MD, PhD - Surgery for Rare Nail Pathology.


Dermfoot
This material is only available to individuals who attended the live event

Dermfoot 2023

Learning Objectives: Upon conclusion of the DERMfoot scientific program, attendees will have an enhanced understanding of:

  • The use of dermoscopy for the evaluation of acral skin and nail pathology
  • The physiology, evaluation, and management of longitudinal melanonychia
  • The science and technique and medico-legal pitfalls in skin and nail biopsy
  • The evaluation, diagnosis, and management of diseases in the skin of color and the use of photomedicine
  • Inflammatory dermatoses, vasculitis, infections of the lower extremity, and their relationship with systemic disease The use of topicals and cryotherapy for treatment and maintenance of pedal pathology.
  • Applications of monoclonal antibodies, antibiotics, antifungals, and their use for skin disease of the foot and ankle
  • The surgical treatment of subungual glomus tumors, benign and malignant nail tumors, and general nail pathology.
  • Advanced skin surgery for the excision of melanoma, SCC, and BCC of the lower extremity
  • Nail matrix biopsy and its technique, indications, and nuances.
  • Wound healing basics, clinical mimics in pedal lesions, and the ten most common podiatric dermatological conditions The Economics of antibiotic stewardship

    • Part 1 - Course Staff

    Eckart Haneke, MD, PhD

    About the Speaker: Assistant Professor Department of Dermatology at the University of Berne, Germany. European Nail Society President.

    Fees

    Free for those that attended the live event

    Intended Audience : Medical Providers

    Refund Policy

    No refunds are available for online courses

    Compliance Statement

    In accordance with the Council on Podiatric Medical Education's Standards and Requirements for Approval of Providers of Continuing Education in Podiatric Medicine, any relevant financial relationships with commercial interests of faculty, planning committee, or any others who have influence over the content of this educational activity must be disclosed to program participants.

    Dermfoot is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. Dermfoot has approved this activity for a maximum of 0.7 continuing education contact hours.

    1. Course Number

      16

    2. Classes Start